XENT stock forecast
Our latest prediction for Intersect ENT, Inc.'s stock price was made on the Sept. 17, 2018 when the stock price was at 29.00$.
In the short term (2weeks), XENT's stock price should outperform the market by 0.54%. During that period the price should oscillate between -6.17% and +7.43%.
In the medium term (3months), XENT's stock price should outperform the market by 0.68%. During that period the price should oscillate between -16.00% and +21.72%.Get email alerts
About Intersect ENT, Inc.
Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA.
At the moment the company generates 108M USD in revenues.
On its last earning announcement, the company reported a loss of -0.76$ per share.
The book value per share is 4.01$
Three months stock forecastSept. 17, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|